CHEK 1 (-7.41%)
IL0011336851Medical Diagnostics & ResearchDiagnostics & Research

Check-Cap (CHEK) Competitor Comparison

We are evaluating the key criteria listed to compare Check-Cap (CHEK) against its competitors in the Diagnostics & Research industry.

Performance 5 years - CHEK ranking 0 / 58

These are the competitors of Check-Cap in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
417.53
2. RadNet RDNT
347.16
3. Lantheus Holdings LNTH
321.69
4. Natera NTRA
276.4
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
110.19
7. Danaher DHR
105.48
8. Mettler-Toledo MTD
92.65
9. Thermo Fisher Scientific TMO
86.63
10. Waters WAT
81.95
11. Agilent Technologies A
80.08
12. Laboratory Corp of America Holdings LH
69.74
13. Charles River Laboratories CRL
69.16
14. IDEXX Laboratories IDXX
64.75
15. DarioHealth DRIO
61.4
16. IQVIA Holdings IQV
59.58
17. Quest Diagnostics DGX
56.8
18. Fulgent Genetics FLGT
54.33
19. PerkinElmer PKI
48.44
20. Icon ICLR
47.8
21. DexCom DXCM
44.16
22. Qiagen QGEN
39.94
23. Co-Diagnostics CODX
23.91
24. CareDx CDNA
19.14
25. Ortho Clinical Diagnostics Holdings OCDX
13.74
26. Heska HSKA
12.14
27. Anixa Biosciences ANIX
-11.57
28. Syneos Health SYNH
-16.98
29. Bioventus BVS
-21.72
30. Myriad Genetics MYGN
-25.76
31. Olink Holding OLK
-26.82
32. NeoGenomics NEO
-28.51
33. Exact Sciences EXAS
-36.08
34. Sotera Health SHC
-40.41
35. Inotiv NOTV
-42.75
36. Illumina ILMN
-46.99
37. Neogen NEOG
-50.06
38. Pacific Biosciences of California PACB
-51.17
39. Sera Prognostics SERA
-55.1
40. Personalis PSNL
-55.13
41. Interpace Biosciences IDXG
-56.97
42. Guardant Health GH
-58.46
43. Enzo Biochem ENZ
-63.14
44. Trinity Biotech TRIB
-65.74
45. National Research NRC
-66.62
46. Psychemedics PMD
-75.16
47. MaxCyte MXCT
-80.11
48. MDxHealth MDXH
-83.29
49. bioAffinity Technologies BIAF
-83.69
50. Exagen XGN
-85.65
51. Global Cord Blood CO
-86.47
52. Precipio PRPO
-87.27
53. Biodesix BDSX
-89.92
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.16

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.